Exelixis (EXEL) Tops Q1 EPS by 10c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.87, $0.10 better than the analyst estimate of $0.77. Revenue for the quarter came in at $610.8 million versus the consensus estimate of $608.95 million.
GUIDANCE:
Exelixis sees FY2026 revenue of $2.525-2.625 billion, versus the consensus of $2.583 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c; Offers Guidance
- Fortis (FTS) Tops Q3 EPS by 28c
- Waters Corp. (WAT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
